Both in Biotechnology
Senti Biosciences Holdings vs Liminatus Pharma
Over the past year SNTI returned −90.4% and LIMN returned −95.9%; their daily moves had a correlation of 0.02.
SNTI −90.4% LIMN −95.9%Growth of $1, one year, split-adjusted
| Metric | SNTI | LIMN |
|---|---|---|
| Price | $0.2151 | $2.92 |
| Market cap | $8.3M | $3.9M |
| Today | +15.21% | +1.04% |
| 1 month | −30.0% | −25.3% |
| 6 months | −78.1% | −71.4% |
| Year to date | −79.3% | −90.4% |
| 1 year | −90.4% | −95.4% |
| Revenue growth (YoY) | — | — |
| Gross margin | 100.0% | — |
| Net margin | −75000.0% | — |
| P/E (TTM) | — | — |
| Price / sales | 150.4× | — |
| Net cash | $2.5M | — |
| Dividend yield | — | — |
| Volatility (60d) | 97.9% | 1,152.8% |
| Short % of float | 4.1% | 4.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).